Tom C. Kouroukis

Hamilton, ON L8N3Z5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

Journal: Current oncology (Toronto, Ont.)

Published: March 30, 2026

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

Journal: British journal of haematology

Published: February 25, 2026

Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective Analysis.

Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective Analysis.

Journal: EJHaem

Published: May 09, 2025

Longitudinal changes in cognition in older individuals receiving lymphoma-directed therapy: A pilot feasibility study.

Longitudinal changes in cognition in older individuals receiving lymphoma-directed therapy: A pilot feasibility study.

Journal: Journal of geriatric oncology

Published: February 04, 2025

Developing Organizational Requirements to Standardize Delivery and Improve Quality of Acute Leukemia Care in Ontario.

Developing Organizational Requirements to Standardize Delivery and Improve Quality of Acute Leukemia Care in Ontario.

Journal: Current oncology (Toronto, Ont.)

Published: July 25, 2024

Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study.

Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study.

Journal: Haematologica

Published: May 01, 2024

A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial.

A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial.

Journal: Journal of geriatric oncology

Published: October 21, 2023

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.

Journal: BMC cancer

Published: August 21, 2023

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.

Journal: Current oncology (Toronto, Ont.)

Published: December 31, 2020

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.

Journal: Leukemia & lymphoma

Published: October 19, 2016

Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline.

Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline.

Journal: Current oncology (Toronto, Ont.)

Published: August 19, 2016

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline.

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 12, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026